Distribute Your News Directly to Readers and Internet Search.
Per Submission
$39.95
Nissan Formula E Team is making final preparations ahead of this weekend’s Berlin E-Prix double-header, which marks Rounds 13 and 14 of the 2024/25 ABB FIA Formula E World Championship.
Robert Daniel Brehm, an accomplished therapist, professor, and author, will showcase his compelling book “The Story Has a Secret: A Sequel” with the self-publishing and book marketing company ReadersMagnet at the upcoming book festival at Printers Row.
While having a relatively peaceful upbringing, veteran and motivational speaker JF Whitaker grew up scarred by his wartime experience in Vietnam. Despite the odds, however, he survives his PTSD and shares his story in his memoir “The Day Before I Died.” As part of his mission to share his empowering message, he is set to exhibit his book at the upcoming Guadalajara …
New research reveals that excess weight is linked to an especially high risk of developing breast cancer in postmenopausal women with cardiovascular disease.
The self-publishing and book marketing company ReadersMagnet will exhibit “The Day Before I Died” by JF Whitaker at the Frankfurt Book Fair 2025.
For all their impressive capabilities, large language models (LLMs) often fall short when given challenging new tasks that require complex reasoning skills.
The President of the Republic of Algeria Abdelmadjid Tebboune has met Eni CEO Claudio Descalzi in Algiers today to discuss the company’s activities in the country, including gas production and export, ongoing and future investments, and energy transition initiatives.
Technology group Wärtsilä will supply a 204 MW power plant solution for the Reko Diq copper-gold mining project in Pakistan. The power plant will operate with 12 Wärtsilä 50 engines and auxiliaries.
Governments still have a chance to protect the future of the deep ocean as the 30th Session of the International Seabed Authority (ISA) resumed, with 37 now calling for a moratorium on deep sea mining – the only credible path to decisively resist predatory corporate seizure and prevent the irreversible harm the industry could unleash.
AstraZeneca’s Imfinzi (durvalumab) has been approved in the European Union (EU) for the treatment of adult patients with resectable muscle-invasive bladder cancer (MIBC) in combination with gemcitabine and cisplatin as neoadjuvant treatment, followed by Imfinzi as monotherapy adjuvant treatment after radical cystectomy (surgery to remove the bladder).